Intra-Cellular Therapies Inc. buy Morgan Stanley
Start price
04.08.23
/
50%
€53.20
Target price
04.08.24
€72.52
Performance (%)
28.76%
End price
05.08.24
€68.50
Summary
This prediction ended on 05.08.24 with a price of €68.50. The BUY prediction by Morgan_Stanley finished with a performance of 28.76%. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intra-Cellular Therapies Inc. | -1.449% | -1.449% | 31.528% |
| iShares Core DAX® | 3.126% | 1.439% | 17.218% |
| iShares Nasdaq 100 | 3.003% | -1.014% | 30.230% |
| iShares Nikkei 225® | 4.991% | 0.755% | 17.870% |
| iShares S&P 500 | 1.852% | -0.402% | 26.313% |
Comments by Morgan_Stanley for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $80.00 price target on the stock.
Ratings data for ITCI provided by MarketBeat
In the thread Trading Intra-Cellular Therapies Inc.
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten